Capitol Hill, California Pose More Challenges For Supplement Industry In 2005
This article was originally published in The Tan Sheet
Executive Summary
The Vioxx recall and other prescription drug crises likely will lead to even more congressional scrutiny of dietary supplements, according to lobbyists working with the industry